Your browser doesn't support javascript.
loading
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes.
Deng, Yangqing; Tu, Dongsheng; O'Callaghan, Chris J; Jonker, Derek J; Karapetis, Christos S; Shapiro, Jeremy; Liu, Geoffrey; Xu, Wei.
Afiliación
  • Deng Y; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
  • O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
  • Jonker DJ; Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.
  • Karapetis CS; Flinders Medical Centre and Flinders University, Adelaide, South Australia, Australia.
  • Shapiro J; Cabrini Hospital and Monash University, Melbourne, Victoria, Australia.
  • Liu G; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Xu W; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Stat Med ; 42(13): 2241-2256, 2023 06 15.
Article en En | MEDLINE | ID: mdl-36998123
ABSTRACT
Many research studies have investigated the relationship between baseline factors or exposures, such as patient demographic and disease characteristics, and study outcomes such as toxicities or quality of life, but results from most of these studies may be problematic because of potential confounding effects (eg, the imbalance in baseline factors or exposures). It is important to study whether the baseline factors or exposures have causal effects on the clinical outcomes, so that clinicians can have better understanding of the diseases and develop personalized medicine. Mendelian randomization (MR) provides an efficient way to estimate the causal effects using genetic instrumental variables to handle confounders, but most of the existing studies focus on a single outcome at a time and ignores the correlation structure of multiple outcomes. Given that clinical outcomes like toxicities and quality of life are usually a mixture of different types of variables, and multiple datasets may be available for such outcomes, it may be much more beneficial to analyze them jointly instead of separately. Some well-established methods are available for building multivariate models on mixed outcomes, but they do not incorporate MR mechanism to deal with the confounders. To overcome these challenges, we propose a Bayesian-based two-stage multivariate MR method for mixed outcomes on multiple datasets, called BMRMO. Using simulation studies and clinical applications on the CO.17 and CO.20 studies, we demonstrate better performance of our approach compared to the commonly used univariate two-stage method.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Análisis de la Aleatorización Mendeliana Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Stat Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Análisis de la Aleatorización Mendeliana Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Stat Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá